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ABSTRACT
Canine distemper virus (CDV), canine adenovirus (CAdV) and canine parvovirus type 2 (CPV-2)
cause disease in dogs (Canis familiaris). These, or closely related viruses, may also infect wild
carnivores. The aim of this study was to investigate exposure to CDV, CAdV and CPV-2 among
fox populations in Norway. Arctic foxes (n = 178) from High-Arctic Svalbard were investigated
for antibodies against CDV. Arctic foxes (n = 301) from Svalbard and red foxes from Low-
Arctic (n = 326) and sub-Arctic (n = 74) regions in Finnmark County, Norway, were investi-
gated for antibodies against CAdV and for the presence of carnivore protoparvovirus DNA in
spleen and mesenteric lymph nodes using polymerase chain reaction. Seroprevalence against
CDV in Arctic foxes decreased from 25% (1995/96) to 6% (2001/02), whereas the seropreva-
lence against CAdV increased from 25–40% during the seasons 1995/96 to 2001/02 to 68%
for the last study year (2002/03). In red foxes, the seroprevalence against CAdV varied
between 31% and 67% for the seasons 2004/05 to 2007/08, increasing to 80% for the last
study year. Carnivore protoparvovirus DNA was not detected in any of the 301 Arctic foxes
and the 265 red foxes investigated. These results show that CDV and CAdV are enzootic in the
Arctic fox population (Svalbard), and that CAdV is enzootic in both the Low-Arctic and sub-
Arctic red fox populations (Finnmark). Further studies are needed to better understand the
infection biology and the impact of CDV and CAdV in these fox populations, and if viruses
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Viruses that are pathogenic to dogs (Canis familiaris),
such as CDV, CAdV and CPV-2, or closely related
viruses, may also infect wild carnivores, including
foxes (Truyen et al. 1998; Steinel et al. 2001;
Aakerstedt et al. 2010; Loots et al. 2016; Walker
et al. 2016).
Canine distemper is a disease caused by CDV
(Paramyxoviridae family, genus Morbillivirus) and
may cause clinical signs in multiple organ systems,
including the central nervous system (Loots et al.
2016). CDV has emerged as a significant disease of
wildlife carnivore species, including several fox spe-
cies and populations, and is regarded as a multi-host
and globally distributed pathogen (Beineke et al.
2015; Bourg et al. 2016; Loots et al. 2016). In a
previous serosurvey, antibodies against CDV were
found in 12% of Arctic foxes (Vulpes lagopus) from
Svalbard and in 12% of red foxes from mainland
Norway (Aakerstedt et al. 2010).
Two types of CAdV (Adenoviridae family, genus
Mastadenovirus), CAdV-1 and CAdV-2, infect dogs
and cause ICH and infectious tracheo-bronchitis,
respectively. CAdV-1 may also be an important
pathogen in foxes, wolves, coyotes, skunks and bears
(Woods 2001; Decaro et al. 2008; Thompson et al.
2010). In foxes, and in contrast to the situation in
dogs, CAdV-1 causes primarily disease in the central
nervous system (Decaro et al. 2008). CAdV-2 has
been detected in a red fox faecal sample, but its
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pathogenic role in wild carnivores is unclear (Balboni
et al. 2013). CAdV has been reported to be enzootic
in many wild carnivore populations, such as coyotes
(Canis latrans) in south-eastern Colorado, USA (Gese
et al. 2004), and in European red fox in Australia
(Robinson et al. 2005) and the UK (Walker et al.
2016). In a previous serosurvey of Arctic foxes from
one trapping site in the Svalbard Archipelago (n = 60)
and red foxes from the mainland Norway (n = 275), a
CAdV seroprevalence of 38% and 60% was found,
respectively, and a seroprevalence of 68% was
detected in the shared Swedish–Norwegian popula-
tion of wolves (Canis lupus) in southern Norway
(Aakerstedt et al. 2010).
Carnivore protoparvovirus 1 (Parvoviridae family,
genus Protoparvovirus), includes viruses that infect
carnivores, of which both CPV-2 and FPV have
been shown to infect foxes (Veijalainen &
Smeds 1988; Truyen et al. 1998; Barker &
Parrish 2001; Steinel et al. 2001). Serological studies
against parvoviruses have revealed a seroprevalence
ranging from 5% to 71% between different fox species
and geographical regions (Truyen et al. 1998; Miller
et al. 2000; Gese et al. 2004; Martino et al. 2004;
Frölich et al. 2005; Sobrino et al. 2008; Millán et al.
2009; Santos et al. 2009; Belsare et al. 2014).
The Arctic fox is the only terrestrial mammalian
predator and the only canid species in the Svalbard
Archipelago (Fuglei 2006). The population of Arctic
fox in Svalbard is regarded as stable, although no firm
population estimate exists (Fuglei et al. 1998; Eide
et al. 2012; Ims et al. 2013; Ims et al. 2014). The
Svalbard Arctic fox belongs to the coastal type,
which lives in areas where no lemmings (Lemmus
spp. or Dicrostonyx spp.) exist, and is therefore a
generalist, associated with both marine and terrestrial
food webs (Prestrud 1992; Frafjord 1993; Eide et al.
2005). Average lifespan is three to four years
(Fuglei 2006). Starvation during winter is regarded
as the main mortality factor (Fuglei & Øritsland 1999;
Fuglei 2006), but a restricted number of foxes are also
hunted during the winter season by fur trappers.
The red fox is distributed throughout mainland
Norway. During the past decades, the red fox has
increased in numbers and distribution, also invading
habitats at higher altitudes and latitudes, and some-
times taking over dens that previously were used by
Arctic foxes (Killengreen et al. 2007; Elmhagen et al.
2017). The red fox is subjected to regular recreational
hunting in Norway. In Finnmark, the northernmost
county of mainland Norway, the recent increase in
the red fox in sub-Arctic and Low-Arctic tundra has
sparked red fox culling programmes in order to
reduce its impact on threatened wildlife species. The
red fox in Finnmark is a generalist predator which
interacts with several other carnivore species
(Killengreen et al. 2011; Ims et al. 2017).
Except for two major rabies epizootics in Svalbard
(1980–81 and 2011; Ødegaard & Krogsrud 1981;
Mørk et al. 2011; Ørpetveit et al. 2011) there are no
reports indicating specific viral epizootics or die-offs
among Arctic foxes in Svalbard or among red foxes in
mainland Norway. The aim of this study was to
investigate if Arctic foxes from eight different loca-
tions in the High-Arctic Svalbard Archipelago, and
red foxes from a Low-Arctic and a sub-Arctic region
in Finnmark County, Norway, were exposed to viral
infections that may affect their disease status and that
also may infect dogs or other carnivore populations.
Methods
Study sites and animals
Arctic foxes (n = 301) were caught in baited traps by
local trappers during the annual harvest at
Spitsbergen, the main island of the Svalbard
Archipelago, Norway (76–81°N, 15–25°E). Samples
were collected during eight trapping seasons
(1 November – and 15 March) from 1995/
96 to 2002/03. Trappers are required to report
their catch to the Governor of Svalbard and deliver
the carcasses for laboratory measurements to the
Norwegian Polar Institute. Arctic foxes were allo-
cated to eight sampling sites (Fig. 1). Red foxes
(n = 400) were shot (September to May) as part of
legal culling programmes in Finnmark County,
Norway, during the hunting seasons 2004/
05 to 2008/09. One location (n = 326) was defined
as the Varanger Peninsula, at the border between
the sub-Arctic and Low-Arctic bioclimatic zones,
whereas the other location (n = 74) was defined as
the sub-Arctic mountain region around the lake
Iešjávri (Fig. 1).
Arctic foxes were trapped and carcasses stored
outside at winter freezing temperatures before they
were brought to a freezer and stored at −20°C until
necropsy. Red fox carcasses were stored immedi-
ately in a freezer at −20°C until necropsy. Age was
determined by counting the cementum annuli of a
sectioned canine tooth (Grue & Jensen 1976). Age
ranged between one and 12 years for both fox
species (Arctic fox: mean 2.2, SD 1.9, red fox:
mean 2.4 years, SD 2.1). Blood was obtained from
the heart or the thoracic or abdominal cavity dur-
ing necropsy and centrifuged at 3500 rpm
for 15 min, and the serum was stored at −20°C
until analysis. Tissue subsamples were frozen at
−20°C until analysis.
CDV serology
A total of 178 Arctic foxes (Svalbard) were tested for
antibodies against CDV (Table 1). Since closely
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related viruses of genus Morbillivirus are circulating
among wildlife species and cross-reacts serologically,
20 animals with antibodies against CDV and 34 sero-
negative animals were tested for antibodies against
phocine distemper virus (PDV) and dolphin morbil-
livirus (DMV) (Table 2). Sera were tested in a virus
neutralization test (VNT) with Vero cells and CDV
(Brussels strain), PDV (PDV-11881N1) and DMV
(DMV-16a), as described previously (Philippa et al.
2004). Results were confirmed by retesting sera using
a plaque neutralization test (CDV; Lederle vaccine
strain) with a Vero cell line with increased suscept-
ibility to CDV attachment and replication, as
described previously (Tryland et al. 2012). Sera from
red foxes were not available for serological screening
for CDV antibodies.
Figure 1. Sampling locations. (a) Arctic fox (Vulpes lagopus) were sampled on Spitsbergen, Svalbard, and red fox (Vulpes vulpes)
in Finnmark County, mainland Norway. (b) Arctic fox were sampled from eight regions on Spitsbergen, Svalbard: 1: Colesdalen
(including Bjørndalen, Grumant, Fuglefjellet and Kapp Laila), 2: Sassendalen and Adventdalen (including Bjonehamna,
Blomsterdalen, De-Geerdalen, Diabas, Endalen, Eskerdalen, Flowerdalen, Foxdalen, Fredheim, Gipsvika, Gruve 3, Revneset,
Tempelet and Vinodden), 3: Farmhamna, 4: Kapp Wijk (including Dicksenfjorden), 5: Austfjordnes, 6: Svea (including
Reindalen), 7: Kongsfjorden (covering the area north of Kongsfjorden and Sarsøya), and 8: Mushamna. (c) Red foxes were
sampled in Low-Arctic ecosystems of Varanger Peninsula and in the sub-Arctic ecosystems in the mountain region around the
lake Iešjávri, Finnmark County, Norway.
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CAdV serology
A total of 301 Arctic foxes and 400 red foxes were
investigated for antibodies against CAdV (Tables 3
and 4). To obtain positive control sera for the CAdV
antibody testing, one blue farmed fox (a colour
morph of the Arctic fox) and one silver fox (a colour
morph of the red fox) kept at the University of Life
Sciences, Norway, were vaccinated twice against
CAdV with a modified live CAdV-2 virus (Nobivac
DHP vet, Intervet/Schering-Plough Animal Health,
Wellington, New Zealand) within an interval
of 14 days. A blood sample was obtained on the day
of the first vaccination, on the day of revaccination
and 14 days after the second vaccination. The sera
were tested with a MegaScreen FLUO HCC-test
(Megacor Diagnostik GmbH, Hörbranz, Austria),
according to the manufacturer’s recommendations
for testing dogs. Briefly, 20 µl of test serum in
a 1:40 dilution in PBS was added to glass-slides cov-
ered with inactivated cells previously infected with
CAdV-1, followed by fluorescence-labelled goat-
anti-dog immunoglobulin G (IgG). The slides were
read at 400× magnification in a fluorescence micro-
scope (Nikon Labophot-2; Nikon Nordic). A positive
reaction was characterized by a strong nuclear, cyto-
plasmic and membrane fluorescence. Interpretation
of the results was based on a comparison of the
fluorescence associated with the test serum compared
with the controls. There were no visible differences
between negative and positive control sera provided
with the kit (dog) and the sera from the two vacci-
nated foxes obtained prior to and 14 days after the
second vaccination, respectively. The samples from
the two vaccinated foxes were therefore used as
Table 1. Arctic foxes (Vulpes lagopus) from Svalbard tested for antibodies against CDV for each trapping site and year, presented
as number of seropositive animals/animals tested.
Year (winter seasona)
Region 95/96 96/97 97/98 98/99 99/00 00/01 01/02 Total
Austfjordnes – 0/11 0/8 1/2 – 1/3 – 2/24
Farmhamna – – – – – 1/6 – 1/6
Kapp Wijk 0/1 3/6 2/8 1/6 2/10 0/15 – 8/46
Kongsfjorden – – – – – – – –
Mushamna – – – – – – 0/1 0/1
Nordenskjöld Land 1/3 4/22 1/16 2/12 – 0/31 1/17 9/101
Total 1/4 7/39 3/32 4/20 2/10 2/55 1/18 20/178
Percentage 25 18 9 20 20 4 6 11
aAll foxes were trapped during the trapping season 1 November to 15 March.
Table 2. Antibody against CDV, PDV and DMV after twofold
serial dilutions of serum samples from Arctic fox (Vulpes
lagopus) from Svalbard, Norway.
Antibody titres
Virus Animals tested ≥16 16 32 64 128 256
CDV 178 20 10 6 2 1 1
PDV 54a 10 2 6 2 – –
DMV 54a 4 2 2 – – –
aThe 20 seropositive foxes (CDV, titer ≥16) and 34 seronegative foxes
were tested for PDV and DMV antibodies.
Titres are presented as 16 for a 1:16 dilution of the serum sample and so
forth, and titres <16 are considered as seronegative.
Table 3. Arctic foxes (Vulpes lagopus) from Svalbard tested for antibodies against CAdV for each trapping site and trapping
season (year), presented as seropositive animals/animals tested.
Year (winter seasona)
Region 95/96 96/97 97/98 98/99 99/00 00/01 01/02 02/03 Sum
Austfjordnes – 3/11 1/11 3/4 – 2/3 – 6/8 15/37
Farmhamna – – – – – 4/8 – – 4/8
Kapp Wijk 0/1 4/7 5/14 5/11 5/12 8/18 – – 27/63
Kongsfjorden – – – – – – – 7/9 7/9
Mushamna – – – – – – 3/3 13/18 16/21
Nordenskjöld Land 2/4 9/27 7/25 2/19 – 10/35 16/38 8/15 54/163
Sum 2/5 16/45 13/50 10/34 5/12 24/64 19/41 34/50 123/301
Percentage 40 36 26 29 42 38 46 68 41
aAll foxes were trapped during the trapping season 1 November to 15 March.
Table 4. Red foxes (Vulpes vulpes) from Iešjávri and Varanger (Finnmark County, Norway) for each hunting season, tested for
antibodies against CAdV and presented as seropositive animals/animals tested.
Year (winter season)
Region 04/05a 05/06 06/07 07/08 08/09 Total
Varanger Peninsula 30/45 43/108 49/120 7/18 30/35 159/326
Iešjávri – – – 18/64 6/10 24/74
Total 30/45 43/108 49/120 25/82 36/45 183/400
Percentage 67 40 41 31 80 46
aAll foxes were shot during the winter season (September to May); hence 04/05 represents the winter of 2004/05, and so forth.
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positive and negative controls, together with the dog
controls provided with the kit. To support the validity
of the test, sera from 41 animals classified as seropo-
sitive (1:40 dilution) were tested in further twofold
dilutions.
CPV-2/FPV PCR
Three hundred and one Arctic foxes (Svalbard,
1995–2003) and 265 red foxes (Varanger
Peninsula, 2005–07) were investigated for CPV-2/
FPV-specific DNA. Mesenteric lymph nodes and
spleen, the organs that have showed the highest
viral load in naturally infected animals
(Greene 2012), were thawed and sub-sampled. The
surface of the tissues was sterilized by open flame,
and a sub-sample was obtained from the centre of
the tissue using a sterile scalpel to avoid contam-
ination between organs and animals. DNA was
extracted from 25 mg of tissue homogenates from
pooled samples, each extract representing five ani-
mals, using a QIAamp DNA Mini Kit (Qiagen).
The whole VP2 gene was targeted with the primers
P1 forward (5ʹ-ATGAGTGATGGAGCAGTTC-3ʹ)
(Battilani et al. 2011) and VP reverse (5ʹ-TTTCTA
GGTGCTAGTTGAG-3ʹ) (Mochizuki et al. 1995),
designed to detect viral DNA of both CPV-2 and
FPV, using the JumpStart REDTaq ReadyMix solu-
tion (Sigma-Aldrich), which produces a fragment
of 1745 bp. A DNA extract of a CPV-2 positive
sample was used as positive control (strain 709/01,
GenBank accession number KF373576).
DNA amplification was performed in a total
volume of 50 μl containing 0.4 µM of each primer,
1X JumpStart REDTaq (Sigma-Aldrich) and 1–200 ng
DNA from each pooled sample unit in 0.2 ml micro-
tubes in a DNA Thermal cycler for 40 cycles (dena-
turation at 94°C for 30 s, annealing at 54°C for 2 min,
and elongation at 72°C for 2 min, followed by a final
elongation step at 72°C for 10 min). PCR products
(5 μl) were separated by electrophoresis in a 1.0%
agarose gel in TAE and visualized by UV light after
staining with SYBR Safe DNA Gel Stain (Bio-Rad
Laboratories AB).
Statistical analyses
The probability of the presence of antibodies against
CAdV and CDV was analysed using logistic regres-
sion models, with a Bernoulli distribution and a logit
link. Models were fitted in R (version 3.3.1; R foun-
dation for Statistical Computing 2016). Four expla-
natory variables were included in the candidate
models: age, sex, the season the fox was trapped/
shot, and region (Fig. 1). In the models, year (i.e.,
winter season), defined as the trapping season for
Arctic fox (November to 15 March) and red fox
(September to May), was treated as a continuous
variable when investigating the exposure of Arctic
fox to CAdV and CDV. In Finnmark, red foxes
were only sampled during two winter seasons in
one of the regions (Iešjávri); hence year (winter sea-
son) was treated as a categorical variable. We assessed
the linearity of relations between the response vari-
able (presence of antibodies against CAdV and CDV)
and the predictor variable year (winter season) in
Svalbard by graphically examining the distribution
of residuals and proportions. Year (winter season)
showed evidence of a nonlinear relation with CAdV
for Arctic fox, and this was adequately described
adding a quadratic term of the explanatory variable
year (winter season). For both viruses and fox species
we formed six a priori candidate models (Burnham &
Anderson 2002): (1) a model considering differences
in exposure to the viruses according to individual
attributes (sex and age); (2) a model considering
exposure to the viruses will change according to age
and year (winter season); (3) a model considering
varying exposure between year (winter season) and
region; (4) a model containing only year (winter
season); (5) a full covariate model; and (6) the null
model (i.e., constant exposure). Initially, we checked
whether predictor variables were correlated using
Spearman’s rank correlation ρ, with ρ > 0.6 as a
threshold. We selected models using the AICc
(Burnham & Anderson 2002). The model with lowest
AICc was chosen unless the differences in AICc were
smaller than 2, in which case the simplest model was
selected (Burnham & Anderson 2002). Goodness-of-
fit of the full model was assessed using the residual
deviance and the le Cessie–van Houwelingen normal
test statistic (Harrell 2015).
Results
Among the Arctic foxes from Svalbard, a seropreva-
lence of 11%, varying from 4% to 25% between the
different years (winter seasons), was found when
testing against CDV as antigen in the VNT assay.
The model that best explained exposure to CDV
included only year (winter season) as an explanatory
variable, showing a general decrease in exposure dur-
ing the sampling period (Fig. 2, Table 5; odds
ratio 0.74 [95% CI: 0.56, 0.97]). The 20 animals hav-
ing antibodies against CDV and 34 seronegative ani-
mals were also tested for PDV and DMV antibodies.
Of the 20 animals with a CDV antibody titre ≥16 (i.e.,
seropositive), 10 and four were also classified as ser-
opositive against PDV and DMV, respectively, but
then with lower titres as compared with when they
were tested against CDV as antigen (Table 2).
Antibodies against CAdV were detected in 41% of
the Arctic foxes, varying from 26% to 68% between
the different years (winter seasons) (Table 3) and
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in 46% of the red foxes, varying from 40% to 80%
between years (winter seasons) (Table 4). When the
sera from 41 animals classified as seropositive to
CAdV at 1:40 dilution were tested in further dilu-
tions, 37 animals remained seropositive at 1:80 dilu-
tion and 33 at 1:160 dilution. Exposure to CAdV in
the Arctic fox was best explained with a model con-
taining year (winter season) and age, whereas for the
red fox, the model that performed best included all
covariates (Supplementary Table S1). For Arctic fox,
there was no increase in exposure to CAdV with age
but there was a clear relationship between exposure
and the year (winter season) of trapping, with the
highest seroprevalence in the last year (trapping sea-
son 2002/03; Fig. 3, Supplementary Table S1). The
proportion of red foxes that tested positive to CAdV
increased with age (Supplementary Table S1; odds
ratio 1.4 [95% CI: 1.13, 1.79]) and was higher in the
Varanger region as compared with Iešjávri
(Supplementary Table S1; odds ratio 2.6 [95% CI:
1.01, 6.46]; Fig. 4). For both these regions, a clear
increase in seroprevalence to CAdV was revealed for
the last year (winter season 2008/09) (Fig. 4). A
comparison of the six candidate statistical models
(Arctic and red fox, CAdV) is presented in
Supplementary Table S1.
No PCR products specific for the VP2 gene of
CPV-2/FPV were detected in any of the investigated
fox tissue samples.
Discussion
Both Arctic and red foxes included in this study were
originally harvested for purposes other than
Figure 2. Predicted probability of exposure (i.e., having anti-
bodies) of Arctic foxes from Svalbard, Norway, to CDV (95%
CI; dotted line) during different years (1996 indicates the
trapping season 1995/96, and so forth), as explained by the
best-fitted logistic regression model. Sample size for each
year is indicated along the x axis.
Table 5. Exposure of Arctic foxes (Vulpes lagopus) to CDV.
Estimate Std. error Z value p
Intercept −2.40 0.31
Year 2000 −0.30 0.14 −2.14 0.033
Null deviance: 125.3 on 178 d.f.
Residual deviance:
120.4 on 177 d.f.
aEstimates from the selected logistic regression indicated that only Year
(intercept is Year 2000) was a significant coefficient (highlighted in
boldface).
Figure 3. Predicted probability of the exposure (i.e., having
antibodies) of Arctic foxes (Vulpes lagopus) from Svalbard,
Norway, to CAdV (95% CI) during different years (1996 indi-
cates the trapping season 1995/96, and so forth), as
explained by the best fitted logistic regression model.
Predictions are shown for an age of two years. Sample size
for each year is indicated along the x axis.
Figure 4. Predicted probability of exposure (i.e., having anti-
bodies) of red foxes (Vulpes vulpes) from Iešjávri and
Varanger, Finnmark County, Norway, to CAdV (95% CI) during
different winter seasons as explained by the best fitted
logistic regression model. Predictions are shown for males
and an age of two years. Sample size for each year is
indicated along the x axis (grey: Varanger, black: Iešjávri).
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investigation for exposure to viruses. Because of sto-
rage conditions, the blood was heavily haemolysed
from most of the carcasses. Strong haemolysis may
hamper some serological tests, but we saw no indica-
tion that the sample quality at a 1:40 dilution had a
negative impact on the performance of the VNT or
the fluorescence test. Similarly, we had no reason to
believe that the storage of tissues at –20°C would
seriously reduce the ability to detect virus-specific
DNA (CPV-2/FPV) with the PCR assay.
The seroprevalence of CDV in Arctic foxes
was 11% (min. 4% in 2000/01, max. 25% in 1995/
96), which is similar to the result from the previous
screening of 60 Arctic foxes from Sassendalen,
Svalbard (Fig. 1b, region 2), reporting a prevalence
of 11.6% (Aakerstedt et al. 2010). Based on the ser-
ological titres found against CDV, PDV and DMV,
respectively (Table 2), the highest seroprevalence and
the highest titres were detected when using CDV as
antigen, indicating that the foxes were truly exposed
to CDV and that the neutralization achieved by these
sera by using PDV and DMV as antigens were due to
immunological cross-reactions against heterologous
viruses.
The seroprevalence detected against CDV among
Arctic foxes from many geographical regions of
Svalbard indicates that this virus is enzootic in this
fox population, although little is known about the
impact of CDV in these animals. In an experimental
study in which red foxes were inoculated with CDV
(strain LN(10)1), the animals showed intermediate
susceptibility to the virus, as compared with raccoon
dogs (Nyctereutes procyonoides) and mink (Neovison
vison), the two latter showing a more severe form and
a milder form of the disease, respectively (Zhao et al.
2015). Of the five experimentally inoculated foxes,
two died at 21 days post inoculation, and showed
immune suppression, such as decreased lymphocyte
proliferation, viremia and restricted amounts of virus
neutralizing antibodies (Zhao et al. 2015). The gen-
eral immunosuppressive effects of CDV (Loots et al.
2016) may increase the impact of parasites and other
infectious agents, resulting in a more severe disease
outcome than caused by those pathogens alone
(Pratelli et al. 2001; Headley et al. 2013).
The use of the test kit designed for detecting anti-
CAdV antibodies in dogs for analysing fox sera was
based on the assumption that the secondary antibody
(goat-anti-dog IgG) also binds fox IgG (Walker et al.
2016). The corresponding performance of the control
sera from dogs provided with the kit and the fox sera
supports the hypothesis that a significant serological
cross-reactivity exists between dog and fox IgG.
Furthermore, the majority of the 41 red fox sera
that tested positive at 1:40 dilution remained positive
upon dilution at 1:80 and 1:160, which also supports
the validity of the test. We conclude that both the
Arctic and red fox populations tested had been
exposed to CAdV-1 or CAdV-2, or a different and
hitherto unknown virus that cross-reacts serologically
with CAdV.
For the Arctic fox, no differences in seroprevalence
against CAdV could be associated with sex or age,
and we also found little variation between years (win-
ter season), except for the last trapping season (2002/
03). The overall CAdV seroprevalence found in this
study (41%, min. 26% in 1997/98, max. 68% in 2002/
03) is in the same range as previously found (38%)
when testing 60 Arctic foxes from one of these
regions, Sassendalen (Fig. 1b, region 2; Aakerstedt
et al. 2010). The relatively high prevalence found
against CAdV in Arctic foxes from a large geographi-
cal region of Spitsbergen suggests that CAdV is
enzootic in the Svalbard population of Arctic foxes.
The seroprevalence for CAdV found among red
foxes (Norwegian mainland) from Varanger
Peninsula and Iešjávri, varying from 31% to 80%
between years (winter seasons) was not much differ-
ent from the prevalence (60%) reported in the pre-
vious study of red foxes in Norway (Aakerstedt et al.
2010). These studies are, however, not directly com-
parable, since the red fox samples in the previous
study originated from the south-east of the country
and our samples were exclusively obtained from
Finnmark County in the north. Further, two different
serological assays were used, a VNT in the previous
study and a fluorescence test in our study, which may
represent differences in sensitivity.
No CPV-2/FPV-specific DNA could be detected by
PCR in any of the tissue samples from Arctic and red
foxes. These findings are in large comparable with
previous studies from Germany, in which the detection
of parvovirus DNA by PCR in tissues either failed
(Frölich et al. 2005) or was possible in only two indi-
viduals (Truyen et al. 1998), in spite of a seroprevalence
of 9% and 13%, respectively, among the investigated
animals. In contrast, a screening of carnivores in
Portugal, including red fox (n = 19) and targeting the
complete VP2 gene (approximately 1.9 kb), revealed
FPV-specific DNA in 15 of the animals, demonstrating
that it is possible to detect CPV-2/FPV-specific DNA in
field samples, using a methodology that targets a long
gene region (Duarte et al. 2013).
On the map, Svalbard appears as a remote archi-
pelago with vast distances to other land masses.
However, when these islands are embraced by sea
ice during winter, the archipelago is physically con-
nected to other Arctic islands and continents.
Satellite tagging of Arctic foxes in Svalbard has
revealed that these animals are able to wander
great distances on sea ice, which is reflected in the
genetic structure of Arctic foxes, showing a high
degree of gene flow between foxes from Svalbard,
Russia, Canada and Alaska (Dalèn et al. 2005;
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Carmichael et al. 2007; Geffen et al. 2007; Norén
et al. 2011). The mobility of Arctic foxes hence
suggests that infectious agents may not necessarily
remain enzootic and stable over time in Arctic fox
populations, but may rather be shared and intro-
duced into different populations from time to time.
In fact, immigration was assumed to have brought
both rabies virus (Ødegaard & Krogsrud 1981;
Mørk et al. 2011; Ørpetveit et al. 2011) and the
parasite Echinococcus multilocularis (Henttonen
et al. 2001) to Svalbard. There is therefore a need
for surveillance of the Arctic fox populations over
time, to gain knowledge of the pathogens that are
circulating and their impact.
Virus infections that are pathogenic to dogs, such as
CDV, CAdV and CPV-2, have recently been detected
in wolves (Canis lupus) living in human-dominated
landscapes (Di Sabatino et al. 2014; Millán et al.
2016). In contrast, the Arctic fox in Svalbard and the
red fox in Finnmark are both populating remote
regions with restricted human settlements and contact
with dogs. Whereas the Arctic fox may have
contact with a very restricted range of other carnivores
(i.e., polar bear [Ursus maritimus] and seals), the red
fox in Finnmark shares habitats with a wide range of
mustelids and other carnivores that could host fox-
relevant pathogens, such as adenoviruses. In spite of
these differences in being exposed to other carnivore
species, the seroprevalence against CAdV were similar
(Tables 3, 4). This was also the case when comparing
seroprevalence among red foxes in Varanger Peninsula
(49%) and in the Iešjávri mountain region (32%), the
latter being farther from human settlements. Although
contact with other carnivores remains as one possible
mode of exchange of pathogens between different host
species, these data indicate that the adenovirus to
which the Arctic fox and red fox populations are
exposed are enzootic and that their epidemiology is
not dependent on other carnivore host species.
Because of the previous rabies epizootics in Arctic
foxes in Svalbard, there is a heightened awareness of
abnormal behaviour among these animals, which could
possibly indicate infectious disease. Since CAdV and
CDV both may cause central nervous system symp-
toms, these virus infections should be regarded as
differential diagnoses to rabies and be included in the
test regime for foxes found dead, sick or exhibiting
abnormal behaviour suspicious of rabies.
Conclusions
This study revealed that CDV and CAdV are enzootic
in the High-Arctic fox population (Svalbard), and that
CAdV is enzootic in the Low-Arctic and sub-Arctic red
fox populations (Finnmark) and with no major differ-
ences in seroprevalence. Since these fox populations
have different contact rates with other carnivores,
these findings indicate that the infection biology of
these viruses is little dependent on other host species.
Causing symptoms from the central nervous system in
carnivores, we suggest that CAdV and CDV should be
regarded as differential diagnoses to rabies. Further
studies are needed to better understand the infection
biology and the potential pathogenic impact of these
viruses on the fox populations, and if they may be
shared with other carnivore hosts, such as dogs.
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